Nicotinic Receptors and Schizophrenia
Study to Evaluate the Safety and Efficacy of MEM 3454 as Adjunctive Treatment in Combination With a Preexisting Antipsychotic in Patients With Cognitive Impairment Associated With Schizophrenia
A Single-Center, Double-Blind (DB) Study of MEM 3454 on P50 Sensory Gating and Mismatch Negativity in Schizophrenia Patients
Use of Galantamine and CDP-choline (Citicoline) to Treat Adults With Schizophrenia
† Study has passed its completion date and status has not been verified in more than two years.